SARS-CoV-2 non-structural proteins and their roles in host immune evasion
Coronavirus disease 2019 (COVID-19) has caused an unprecedented global crisis and
continues to threaten public health. The etiological agent of this devastating pandemic …
continues to threaten public health. The etiological agent of this devastating pandemic …
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
X Li, Z Zhang, Z Wang… - Signal transduction and …, 2022 - nature.com
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has dramatically influenced …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has dramatically influenced …
Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been significantly
paralyzing the societies, economies and health care systems around the globe. The …
paralyzing the societies, economies and health care systems around the globe. The …
Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies
Background There are multiple reviews on cardiovascular aspects of COVID-19 disease on
cardiovascular system in different population but there is lack of evidence about …
cardiovascular system in different population but there is lack of evidence about …
An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: A comprehensive review
S Moneshwaran, D Macrin, N Kanagathara - International Journal of …, 2024 - Elsevier
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a highly
contagious and dangerous virus that caused the global COVID-19 pandemic in early 2020. It …
contagious and dangerous virus that caused the global COVID-19 pandemic in early 2020. It …
[HTML][HTML] Structural comparison and drug screening of spike proteins of ten SARS-CoV-2 variants
Abstract SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has evolved many
variants with stronger infectivity and immune evasion than the original strain, including …
variants with stronger infectivity and immune evasion than the original strain, including …
Pharmaceutical prospects of curcuminoids for the remedy of COVID-19: Truth or myth
YS Fu, WY Ho, N Kang, MJ Tsai, J Wu… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), which is a positive-strand RNA virus, and has rapidly spread …
coronavirus 2 (SARS-CoV-2), which is a positive-strand RNA virus, and has rapidly spread …
Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19
Q Jin, W Li, W Yu, M Zeng, J Liu, P Xu - Computers in biology and medicine, 2022 - Elsevier
COVID-19 pandemic poses a severe threat to public health. However, so far, there are no
effective drugs for COVID-19. Transcriptomic changes and key genes related to Th2 cells in …
effective drugs for COVID-19. Transcriptomic changes and key genes related to Th2 cells in …
Identification of critical genes and molecular pathways in COVID-19 myocarditis and constructing gene regulatory networks by bioinformatic analysis
F Zhang, C Yu, W Xu, X Li, J Feng, H Shi, J Yang… - Plos one, 2022 - journals.plos.org
Background There is growing evidence of a strong relationship between COVID-19 and
myocarditis. However, there are few bioinformatics-based analyses of critical genes and the …
myocarditis. However, there are few bioinformatics-based analyses of critical genes and the …
Repurposing of drugs against methyltransferase as potential Zika virus therapies
In recent years, the outbreak of infectious disease caused by Zika Virus (ZIKV) has posed a
major threat to global public health, calling for the development of therapeutics to treat ZIKV …
major threat to global public health, calling for the development of therapeutics to treat ZIKV …